is semaglutide a controlled substance The FDA's Decision to Ban Compounds: What You Need to Know FDA Ban on Compounded GLP-1

If you have, then you should be able to continue with the treatment if it is working for you and not causing any major side effects

GoodRx is well positioned to help pharmaceutical manufacturers sell their brands directly to patients because we already operate at the intersection of pricing transparency, patient engagement, and pharmacy fulfillment, which are the core building blocks of a DTC model. Looking ahead, Iyer said GoodRx plans to launch a GLP-1 subscription model later this year, which will streamline the process for consumers to consult with healthcare professionals, determine eligibility, and access FDA-approved medications

Long-term studies have shown even more significant reductions, with weight loss continuing over 48 weeks

Healthcare systems can implement additional safeguards, including electronic prescribing systems with built-in dose range checking, patient education materials in multiple formats (written, video, pictorial), and follow-up contact after initiation or dose escalation to assess tolerance and adherence

Wegovy and Saxenda, both injectables, are the only GLP-1s FDA-approved for obesity